Retrospective analysis of the safety and efficacy of vandetanib as systemic treatment for patients with advanced and progressive medullary thyroid cancer (MTC)

被引：0
|
作者：
Capdevila, Jaume
Martinez-Trufero, Javier
Dalmau, Elsa
Alvarez-Escala, Cristina
Beltran, Miguel
Duran, Manuel
Gallegos, Isabel
Luis Manzano, Jose
Mesla, Ricard
Pajares, Isabel
Fuentes Pradera, Jose
Grau, Juan J.
Reig, Oscar
Manuel Trigo, Jose
Grande, Enrique
机构：
[1] Vall dHebron Univ Hosp, Barcelona, Spain
[2] Hosp Miguel Servet, Zaragoza, Spain
[3] Univ Autonoma Barcelona, Corp Sanitaria Univ Parc Tauli, Sabadell, Spain
[4] La Paz Univ Hosp, Dept Endocrinol, Madrid, Spain
[5] Hosp Univ Josep Trueta, Inst Catala Oncol, Girona, Spain
[6] Rey Juan Carlos Univ Hosp, Madrid, Spain
[7] Hosp Gen Segovia, Segovia, Spain
[8] Hosp Badalona Germans Trias & Pujol, Inst Catala Oncol, Badalona, Spain
[9] Catalan Inst Oncol, Barcelona, Spain
[10] Hosp Univ Miguel Servet, Zaragoza, Spain
[11] Hosp Univ Virgen de Valme, Seville, Spain
[12] Hosp Clin Barcelona, Barcelona, Spain
[13] Hosp Univ Virgen de la Victoria, Malaga, Spain
[14] Hosp Univ Ramon y Cajal, Dept Med Oncol, Madrid, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e17016
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Vandetanib (ZD6474) in the Treatment of Medullary Thyroid Cancer
    Deshpande, Hari
    Roman, Sanziana
    Thumar, Jaykumar
    Sosa, Julie Ann
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2011, 5 : 213 - 221
  • [32] Vandetanib: opening a new treatment practice in advanced medullary thyroid carcinoma
    Cosimo Durante
    Alessandra Paciaroni
    Katia Plasmati
    Fabiana Trulli
    Sebastiano Filetti
    Endocrine, 2013, 44 : 334 - 342
  • [33] Pazopanib, Cabozantinib, and Vandetanib in the Treatment of Progressive Medullary Thyroid Cancer with a Special Focus on the Adverse Effects on Hypertension
    Milling, Rikke Vilsboll
    Grimm, Daniela
    Krueger, Marcus
    Grosse, Jirka
    Kopp, Sascha
    Bauer, Johann
    Infanger, Manfred
    Wehland, Markus
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (10)
  • [34] Pretargeted radioimmunotherapy (pRAIT) in progressive medullary thyroid cancer (MTC)
    Salaun, Pierre
    Bournaud, Claire
    Bardet, Stephane
    Vuillez, Jean-Philippe
    Taieb, David
    Ansquer, Catherine
    Barbet, Jacques
    Goldenberg, David
    Chatal, Jean-Francois
    Kraeber-Bodere, Francoise
    JOURNAL OF NUCLEAR MEDICINE, 2011, 52
  • [35] Vandetanib, in the management of patients with locally advanced or metastatic medullary thyroid carcinomas
    Chougnet, Cecile N.
    Schlumberger, Martin
    Leboulleux, Sophie
    Baudin, Eric
    BULLETIN DU CANCER, 2014, 101 (09) : 891 - 895
  • [36] Efficacy and safety of pralsetinib in Chinese advanced RET-mutant medullary thyroid cancer patients
    Zheng, Xiangqian
    Fang, Meiyu
    Fan, Yun
    Sun, Yuping
    Sun, Meili
    Yang, Ankui
    Zhang, Bin
    Liu, Qinjiang
    Liu, Hui
    Zhou, Xiaohong
    Huang, Tao
    Qin, Jianwu
    Wang, Zhaohui
    Qin, Mengmeng
    Shen, Zhenwei
    Yao, Sheng
    Yang, Jason
    Wang, Yu
    Gao, Ming
    ENDOCRINE-RELATED CANCER, 2024, 31 (04)
  • [37] First Line Sorafenib Treatment for Metastatic Medullary Thyroid Cancer: Efficacy and Safety Analysis
    Kocsis, Judit
    Szekanecz, Eva
    Bassam, Ali
    Uhlyarik, Andrea
    Papai, Zsuzsanna
    Rubovszky, Gabor
    Mezosi, Emese
    Rucz, Karoly
    Garai, Ildiko
    Nagy, Endre
    Uray, Ivan
    Horvath, Zsolt
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2019, 127 (04) : 240 - 246
  • [38] TREATMENT WITH VANDETANIB IN A 11 YEARS OLD BOY WITH ADVANCED MEDULLARY THYROID CARCINOMA
    Papendieck, Patricia
    Vieites, Ana
    Elias, Eugenia
    Garcia Lombardi, Mercedes
    Chiesa, Ana
    HORMONE RESEARCH IN PAEDIATRICS, 2017, 88 : 596 - 596
  • [39] Vandetanib for the Treatment of Advanced Medullary Thyroid Cancer Outside a Clinical Trial: Results from a French Cohort
    Chougnet, Cecile N.
    Borget, Isabelle
    Leboulleux, Sophie
    de la Fouchardiere, Christelle
    Bonichon, Francoise
    Criniere, Lise
    Niccoli, Patricia
    Bardet, Stephane
    Schneegans, Olivier
    Zanetta, Sylvie
    Schvartz, Claire
    Drui, Delphine
    Chauffert, Bruno
    Rohmer, Vincent
    Schlumberger, Martin
    THYROID, 2015, 25 (04) : 386 - 391
  • [40] Rapid response of hypercortisolism to vandetanib treatment in a patient with advanced medullary thyroid cancer and ectopic Cushing syndrome
    Pitoia, Fabian
    Bueno, Fernanda
    Schmidt, Angelica
    Lucas, Sabrina
    Cross, Graciela
    ARCHIVES OF ENDOCRINOLOGY METABOLISM, 2015, 59 (04): : 343 - 346
12345